NCT07021209View on ClinicalTrials.gov

GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases

PHASE1RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 14, 2025

Primary Completion Date

January 13, 2028

Study Completion Date

January 13, 2028

Conditions

Neurological Autoimmune Diseases

Interventions

BIOLOGICAL

GT719 Injection

GT719 Injection

Trial Locations (1)

Unknown

RECRUITING

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

collaborator

Tongji Hospital

OTHER

lead

Grit Biotechnology

INDUSTRY